NO20011403D0 - Terapi for Õ forbedre kongestion - Google Patents
Terapi for Õ forbedre kongestionInfo
- Publication number
- NO20011403D0 NO20011403D0 NO20011403A NO20011403A NO20011403D0 NO 20011403 D0 NO20011403 D0 NO 20011403D0 NO 20011403 A NO20011403 A NO 20011403A NO 20011403 A NO20011403 A NO 20011403A NO 20011403 D0 NO20011403 D0 NO 20011403D0
- Authority
- NO
- Norway
- Prior art keywords
- therapy
- improve congestion
- congestion
- improve
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203454 | 1998-10-16 | ||
| PCT/EP1999/007804 WO2000023057A2 (en) | 1998-10-16 | 1999-10-12 | Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20011403D0 true NO20011403D0 (no) | 2001-03-20 |
| NO20011403L NO20011403L (no) | 2001-03-20 |
Family
ID=8234219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011403A NO20011403L (no) | 1998-10-16 | 2001-03-20 | Terapi for å forbedre kongestion |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1121131A2 (xx) |
| JP (1) | JP2002527469A (xx) |
| KR (1) | KR20010072878A (xx) |
| CN (1) | CN1367697A (xx) |
| AU (1) | AU6472799A (xx) |
| BG (1) | BG105302A (xx) |
| BR (1) | BR9914419A (xx) |
| CA (1) | CA2345767A1 (xx) |
| EE (1) | EE200100136A (xx) |
| HK (1) | HK1039745A1 (xx) |
| HR (1) | HRP20010262A2 (xx) |
| HU (1) | HUP0103781A3 (xx) |
| ID (1) | ID28441A (xx) |
| IL (1) | IL142588A0 (xx) |
| NO (1) | NO20011403L (xx) |
| PL (1) | PL348107A1 (xx) |
| SK (1) | SK4592001A3 (xx) |
| TR (1) | TR200101082T2 (xx) |
| WO (1) | WO2000023057A2 (xx) |
| ZA (1) | ZA200103081B (xx) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006201188B2 (en) * | 2001-02-05 | 2007-11-15 | Novartis Ag | New use of iloperidone |
| GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
| CA2463158C (en) * | 2001-10-30 | 2013-07-30 | Novartis Ag | Depot formulations of iloperidone and a star polymer |
| GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
| US20040192754A1 (en) * | 2003-03-24 | 2004-09-30 | Shapira Nathan Andrew | Methods for treating idiopathic hyperhidrosis and associated conditions |
| TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
| WO2006065233A1 (en) * | 2004-12-10 | 2006-06-22 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| US20050232990A1 (en) * | 2003-12-31 | 2005-10-20 | Garth Boehm | Donepezil formulations |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| EP2091948B1 (en) | 2006-11-30 | 2012-04-18 | Probiodrug AG | Novel inhibitors of glutaminyl cyclase |
| CN101668525A (zh) | 2007-03-01 | 2010-03-10 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶抑制剂的新用途 |
| US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| MX2007008642A (es) * | 2007-07-16 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias. |
| EA037187B1 (ru) | 2010-02-09 | 2021-02-17 | Дзе Джонс Хопкинс Юниверсити | Способ и композиция для лечения когнитивного расстройства |
| WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
| CA2789440C (en) | 2010-03-10 | 2020-03-24 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| JP6433482B2 (ja) | 2013-03-15 | 2018-12-05 | エージンバイオ, インコーポレイテッド | 認知機能を改善するための方法および組成物 |
| AU2016268096B2 (en) | 2015-05-22 | 2021-04-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992020327A1 (en) * | 1991-05-14 | 1992-11-26 | Ernir Snorrason | Treatment of fatigue syndrome with cholinesterase inhibitors |
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| CA2300148C (en) * | 1997-08-11 | 2009-06-23 | University Of South Florida | Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
| CA2328197C (en) * | 1998-04-14 | 2007-11-20 | The General Hospital Corporation | Methods for treating neuropsychiatric disorders |
-
1999
- 1999-10-12 HK HK02100158.6A patent/HK1039745A1/zh unknown
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Withdrawn
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Ceased
-
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/no not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6472799A (en) | 2000-05-08 |
| KR20010072878A (ko) | 2001-07-31 |
| HUP0103781A2 (hu) | 2002-03-28 |
| WO2000023057A3 (en) | 2000-07-27 |
| EP1121131A2 (en) | 2001-08-08 |
| ZA200103081B (en) | 2002-07-12 |
| HK1039745A1 (zh) | 2002-05-10 |
| HUP0103781A3 (en) | 2003-09-29 |
| IL142588A0 (en) | 2002-03-10 |
| PL348107A1 (en) | 2002-05-06 |
| WO2000023057A2 (en) | 2000-04-27 |
| SK4592001A3 (en) | 2001-12-03 |
| BG105302A (en) | 2001-11-30 |
| ID28441A (id) | 2001-05-24 |
| CA2345767A1 (en) | 2000-04-27 |
| EE200100136A (et) | 2002-06-17 |
| TR200101082T2 (tr) | 2001-09-21 |
| BR9914419A (pt) | 2001-06-26 |
| JP2002527469A (ja) | 2002-08-27 |
| CN1367697A (zh) | 2002-09-04 |
| NO20011403L (no) | 2001-03-20 |
| HRP20010262A2 (en) | 2002-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20011403D0 (no) | Terapi for Õ forbedre kongestion | |
| IS6340A (is) | Vatnsgel-knúið lyfjaskammtaform | |
| ID27841A (id) | Turunan-turunan biaril terapeutik | |
| NO20003640D0 (no) | Ny doseringsform | |
| DE59910140D1 (de) | Gleitschalungsfertiger | |
| ID26974A (id) | Ketoenol siklik arilfenil-tersubstitusi | |
| DK1637127T3 (da) | Terapeutisk mikroskum | |
| NO992692D0 (no) | Nefadozon doseringsform | |
| DE69941252D1 (de) | Geriffelte elektroden | |
| ATE321483T1 (de) | Dose | |
| FR2806140B1 (fr) | Volant divise | |
| DE69936958D1 (de) | Verkehrsformer | |
| IS6686A (is) | Hýdrógel-drifið lyfjaskömmtunarform | |
| ID28648A (id) | Perangkat penyerapan inter-labial | |
| DE69921571D1 (de) | Massagegerät | |
| EE200200568A (et) | Ravis kasutatavad difenüüleetriühendid | |
| IS6563A (is) | Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka | |
| DE60037935D1 (de) | Kontinuierliches behandlungssystem | |
| NO20005042D0 (no) | FremgangsmÕter for Õ inhibere MRP1 | |
| NO994872D0 (no) | Reisesafe | |
| IT1310385B1 (it) | Dispositivo per migliorare la respirazione. | |
| NO20023164L (no) | Buekonstruksjon | |
| IS5877A (is) | Ný efnablanda | |
| IS5879A (is) | Ný efnablanda | |
| IT1299030B1 (it) | Dispositivo per produrre scarpe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |